.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery
Ryan J. . Ed(S): Sullivan
€ 127.88
FREE Delivery in Ireland
Description for BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery
hardcover. BRAF Targets in Melanoma Editor(s): Sullivan, Ryan J. Series: Cancer Drug Discovery and Development. Num Pages: 212 pages, 5 black & white illustrations, 21 colour illustrations, 5 black & white tables, biography. BIC Classification: MJCL; MJK. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 13. Weight in Grams: 485.
This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, ... Read more
This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, ... Read more
Product Details
Format
Hardback
Publication date
2014
Publisher
Humana United States
Number of pages
212
Condition
New
Series
Cancer Drug Discovery and Development
Number of Pages
204
Place of Publication
Totowa, NJ, United States
ISBN
9781493921423
SKU
V9781493921423
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
About Ryan J. . Ed(S): Sullivan
Dr. Ryan J. Sullivan is affiliated with Massachusetts General Hospital and Dana Farber. His research interests are in the development of novel molecular therapeutic agents for Kaposi sarcoma (KS) and malignant melanoma and the translation of promising preclinical findings into early stage clinical trials. He serves as the co-director of the Eugene Michael Egan Melanoma Translational Research Laboratory at Beth ... Read more
Reviews for BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery